학술논문
ATLAS trial of adjuvant axitinib in patients with renal cell carcinoma: subgroup analyses with focus on axitinib dosing and racial groups
Document Type
Article
Author
Source
In ESMO Open June 2021 6(3)
Subject
Language
ISSN
2059-7029